Literature DB >> 7096475

Reversed-phase ion-pair high-performance liquid chromatography of mercaptoacetate and N-acetylcysteine after derivatization with N-(1-pyrene)maleimide and N-(7-dimethylamino-4-methyl-3-coumarinyl)maleimide.

B Kågedal, M Källberg.   

Abstract

We have developed a high-performance liquid chromatographic system capable of resolving mercaptoacetate and N-acetylcysteine as their N-(1-pyrene)maleimide (PM) and N-(7-dimethylamino-4-methyl-3-coumarinyl)maleimide (DACM) derivatives. Good resolution was obtained by ion pairing with tetramethylammonium hydroxide and chromatography on reversed phase. The detection limits for the thiols were about 50 fmol as their DACM derivatives and about 400 fmol as their PM derivatives. The method is illustrated by chromatography of urinary thiols which indicates that the derivatization and chromatography procedures should be well applicable in bioanalytical work.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 7096475     DOI: 10.1016/s0378-4347(00)84283-8

Source DB:  PubMed          Journal:  J Chromatogr


  3 in total

1.  Pharmacokinetics of N-acetylcysteine in man.

Authors:  L Borgström; B Kågedal; O Paulsen
Journal:  Eur J Clin Pharmacol       Date:  1986       Impact factor: 2.953

Review 2.  Bottom-up analysis of emergent properties of N-acetylcysteine as an adjuvant therapy for COVID-19.

Authors:  Asimina Dominari; Donald Hathaway Iii; Abdulhusein Kapasi; Trissa Paul; Sarabjot Singh Makkar; Valeria Castaneda; Sirisha Gara; Bishnu Mohan Singh; Kuchalambal Agadi; Maliha Butt; Varadha Retnakumar; Spandana Chittajallu; Rahima Taugir; Muhammad Khawar Sana; Manish Kc; Sarah Razzack; Niala Moallem; Alina Alvarez; Michael Talalaev
Journal:  World J Virol       Date:  2021-03-25

3.  Fluorimetric determination of some sulfur containing compounds through complex formation with terbium (Tb+3) and uranium (U+3).

Authors:  Elham Anwer Taha; Nagiba Yehya Hassan; Fahima Abdel Aal; Laila El-Sayed Abdel Fattah
Journal:  J Fluoresc       Date:  2007-04-18       Impact factor: 2.525

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.